Human Reproduction, Vol. 15, No. suppl_1, pp. 46-59, 2000
© 2000 European Society of Human Reproduction and Embryology
Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss
1 Recurrent Miscarriage Clinic, Samsung Cheil Hospital and Women's Healthcare Center, College of Medicine, Sungkyunkwan University Seoul, Korea 2 The Fearing Laboratory, Division of Reproductive Immunology, Harvard Medical School Boston, MA, USA 3 The Center for Reproductive Medicine, Division of Reproductive Medicine, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA
Correspondence: 4To whom correspondence should be addressed at: Reproductive Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
A dichotomous T-helper 1 (Thl) versus T-helper 2 (Th2) cytokine response to trophoblast has been proposed to mediate reproductive failure and success, respectively. Progesterone has immunosuppressive properties. In this study, peripheral blood mononuclear cells from women with and without unexplained recurrent pregnancy loss who had and did not have evidence of embryotoxic, Thl immunity to trophoblast were cultured with progesterone (10–5 mol/1) or interleukin (IL)-10 (1500 pg/ml) to determine whether these agents were capable of inhibiting embryotoxic, Thl immunity to trophoblast. The effects of progesterone on Th2 cytokines and transforming growth factor (TGF)-β secretion were also assessed. Progesterone was found to specifically block Thl immunity to trophoblast, as was IL-10. Progesterone also appeared to upregulate TGF-β secretion in response to trophoblast but had no effect on Th2 cytokine secretion. Our data suggest that assaying Thl cytokines in supernatants of peripheral blood mononuclear cells cultured with a protein extract from trophoblast may identify individuals more likely to benefit from potentially immunosuppressive doses of progesterone. An appropriately designed clinical trial is needed to determine whether therapies modifying Thl cytokine secretion in response to trophoblast are useful in the clinical management of recurrent pregnancy loss in women producing these cytokines in response to reproductive antigen stimulation.
Key words: embryotoxicity/progesterone/recurrent abortion/Thl cytokines
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Blanco, I. Tirado, R. Munoz-Fernandez, A. C. Abadia-Molina, J. M. Garcia-Pacheco, J. Pena, and E. G. Olivares Human decidual stromal cells express HLA-G Effects of cytokines and decidualization Hum. Reprod., January 1, 2008; 23(1): 144 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goldman and E. Shalev Difference in Progesterone-Receptor Isoforms Ratio Between Early and Late First-Trimester Human Trophoblast Is Associated with Differential Cell Invasion and Matrix Metalloproteinase 2 Expression Biol Reprod, January 1, 2006; 74(1): 13 - 22. [Abstract] [Full Text] [PDF]
|
|